Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
Jonathan Kwan is an Assistant Professor of Philosophy at New York University Abu Dhabi and was previously the Markkula Center’s Inclusive Excellence Postdoctoral Fellow in Immigration Ethics. Views ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results